hotspot -WSS

hotspot

author：fashion 2025-08-23 18:39:02 - browse：9337

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

explore

WSS

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Former Georgia lieutenant governor says he received grand jury subpoena

PBM reform efforts get punted in Congress

He's a Nobel laureate. Critics say he was misleading on Covid

A solution to the after

Zapping the brain for stroke rehab: Pivotal clinical trial begins

hotspot

hotspot

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare inequities exacerbate Puerto Rico’s health disparities

DIEP, the 'gold standard' of breast reconstruction, is under threat

New documents shed light on MD Anderson Cancer Institute feud

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Harvard botanist who searched for psychedelics in the Amazon

Peter Hotez and the public health issue of online harassment

Choosing scientific sides in the fight against Alzheimer's

focus

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Alabama IVF ruling threatens families facing fatal genetic disease

Dario to buy mental health app maker Twill in cash and stock deal

Lessons Learned: This is why you network to find that industry job you want

Choosing scientific sides in the fight against Alzheimer's

explore

focus

explore

focus